Keywords: avonex, gets, eu, ok, high-risk, ms, patients

Avonex gets EU OK for high-risk MS patients

Article | 27 May 2002

Print This

Biogen has been under pressure to protect its multiple sclerosisfranchise of late in the face of growing competition, and news ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in